Back to Newsroom
Back to Newsroom

SHAREHOLDER ALERT: PRA CEMI WRCDF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Thursday, 06 August 2020 06:20 AM

The Law Offices of Vincent Wong

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / August 6, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

ProAssurance Corporation (NYSE:PRA)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/proassurance-corporation-loss-submission-form?prid=8403&wire=1
Lead Plaintiff Deadline: August 17, 2020
Class Period: April 26, 2019 - May 7, 2020

Allegations against PRA include that: (i) ProAssurance lacked adequate underwriting process and risk management controls necessary to set appropriate loss reserves in its Specialty P&C segment; (ii) ProAssurance failed to properly assess a large national healthcare account that experienced losses far exceeding the assumptions made when the account was underwritten; and (iii) as a result, ProAssurance was subject to materially heightened risk of financial loss and reserve charges.

Chembio Diagnostics, Inc. (NASDAQ:CEMI)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/chembio-diagnostics-inc-loss-submission-form?prid=8403&wire=1
Lead Plaintiff Deadline: August 17, 2020
Class Period: March 12, 2020 - June 16, 2020

According to the filed complaint, defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated Chembio's stock price and operated as a fraud or deceit by misrepresenting the efficacy of the Company's Dual Path Platform ("DPP") COVID-19 test. Defendants allegedly achieved this by making false statements about Chembio's DPP COVID-19 test, although they knew or at least recklessly disregarded that there were material performance concerns with the test. When defendants' prior misrepresentations were disclosed and became apparent to the market, the price of Chembio stock fell precipitously as the prior artificial inflation came out of Chembio's stock price.

Wirecard AG (OTC PINK:WRCDF)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/wirecard-ag-loss-submission-form-2?prid=8403&wire=1
Lead Plaintiff Deadline: September 8, 2020
Class Period: August 17, 2015 - June 24, 2020

Allegations against WRCDF include that: (1) Wirecard overstated its cash balances during the Class Period, falsely claiming €1.9 billion of cash in a trust account that was missing; (2) Wirecard overstated its financial results during the Class Period, including revenue and EBITDA; (3) Wirecard did not have adequate risk management or countermeasures; (4) the Company's external auditor failed to audit Wirecard in accordance with applicable auditing principles; and (5) as a result, Defendants' statements about Wirecard's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]

SOURCE: The Law Offices of Vincent Wong

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: